SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020
GHDx Entry last modified on: Mar 14, 2022
COVID-19
Dataset Records for COVID-19
Displaying 1151 - 1200 of 1369
Clinico-Radiological Features and Outcomes in Pregnant Women with COVID-19 Pneumonia Compared with Age-Matched Non-Pregnant Women
GHDx Entry last modified on: Mar 14, 2022
Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App
GHDx Entry last modified on: Apr 10, 2023
Maternal and neonatal outcomes in COVID-19 infected pregnancies: a prospective cohort study
GHDx Entry last modified on: Mar 14, 2022
Canada - Daily Epidemiologic Summary of COVID-19 in Ontario 2020
Epidemiologic Summary COVID-19 in Ontario
Higher SARS-CoV-2 Infection Rate in Pregnant Patients
GHDx Entry last modified on: Jan 31, 2024
[Assessment of population immunity to SARS-CoV-2 among the population of the Leningrad region during the COVID-19 epidemic]
Оценкa популяционого имм унитета к SARS-CoV-2 среди населения Ленинградск ой области в период эпидемии COVID-19
Author Correction: A global survey of potential acceptance of a COVID-19 vaccine
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1)
GHDx Entry last modified on: Jun 17, 2021
Global COVID-19 Routine Childhood Vaccination Disruption 2020
GHDx Entry last modified on: Feb 5, 2024
Performance of rapid IgM-IgG combined antibody tests in the occupational surveillance of COVID-19 in Colombian enterprises
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
GHDx Entry last modified on: Jan 31, 2024
A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
GHDx Entry last modified on: May 12, 2022
Interventional pain management during SARS-CoV-2 pandemic
GHDx Entry last modified on: Mar 14, 2022
[Humoral immunity to SARS-CoV-2 in the population of the Murmansk region against the background of the incidence of COVID-19]
ГУМОРАЛЬНЫЙ ИММУНИТЕТ К SARS-CoV-2 У НАСЕЛЕНИЯ МУРМАНСКОЙ ОБЛАСТИ НА ФОНЕ ЗАБОЛЕВАЕМОСТИ COVID-19
Prevalence of Anti-SARS-CoV-2 Antibodies in Poznań, Poland, after the First Wave of the COVID-19 Pandemic
GHDx Entry last modified on: Mar 14, 2022
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors
GHDx Entry last modified on: Mar 14, 2022
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
GHDx Entry last modified on: Mar 14, 2022
Six-Month Outcomes in Patients Hospitalized with Severe COVID-19
GHDx Entry last modified on: Jan 31, 2024
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
GHDx Entry last modified on: Jan 31, 2024
Metodología de la Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19
GHDx Entry last modified on: Mar 14, 2022
Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study. Preprint
GHDx Entry last modified on: May 12, 2022
Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
GHDx Entry last modified on: Jan 31, 2024
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in people with and without HIV in rural Western Kenya, January to March 2020
GHDx Entry last modified on: Jan 31, 2024
Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, Mexico
GHDx Entry last modified on: Jan 31, 2024
Clinical and Pregnancy Outcomes of Coronavirus Disease 2019 Among Hospitalized Pregnant Women in the United States
GHDx Entry last modified on: Apr 10, 2023
Obstetric Observatory BRAZIL - COVID-19: 1031 maternal deaths because of COVID-19 and the unequal access to health care services
GHDx Entry last modified on: Apr 10, 2023
Social determinants of health and coronavirus disease 2019 in pregnancy
GHDx Entry last modified on: Apr 10, 2023
Long COVID in children and adolescents: COVID-19 follow-up results in third-level pediatric hospital
GHDx Entry last modified on: Mar 22, 2024
Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors
GHDx Entry last modified on: Mar 22, 2024
Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome
GHDx Entry last modified on: Mar 22, 2024
Post-COVID-19 syndrome and humoral response association after 1year in vaccinated and unvaccinated patients
GHDx Entry last modified on: Mar 22, 2024
Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot study
GHDx Entry last modified on: Mar 22, 2024
Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City
GHDx Entry last modified on: Mar 22, 2024
Sri Lanka Epidemiology Unit Coronavirus Disease 2019 (COVID-19) Situation Report 2020-2022
Coronavirus disease 2019 (COVID-19) - Situation Report
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
GHDx Entry last modified on: Mar 14, 2022
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states. Preprint
Scientific literature:
Household
Seroprevalence of COVID-19 in Niger State. Preprint
GHDx Entry last modified on: Mar 4, 2024
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort
GHDx Entry last modified on: Jan 31, 2024
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia
GHDx Entry last modified on: Jan 31, 2024
Persistent Symptoms in Patients After Acute COVID-19
GHDx Entry last modified on: Apr 10, 2023
Racial-ethnic disparities and pregnancy outcomes in SARS-CoV-2 infection in a universally-tested cohort in Houston, Texas
GHDx Entry last modified on: Jan 31, 2024
A snapshot of the Covid-19 pandemic among pregnant women in France
GHDx Entry last modified on: Mar 14, 2022
[The experience of the study of seroprevalence to the SARS-CoV-2 virus in the population of the Irkutsk region during the COVID-19 outbreak]
Опыт исс ледования серопревалентности к вирусу SARS-CoV-2 населения Иркутск ой области в период вспышки COVID-19
Brazil - Severe Acute Respiratory Syndrome Database - including data from COVID-19 2020-2022
Severe Acute Respiratory Syndrome Database - including COVID-19 data
Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study. Preprint
GHDx Entry last modified on: Sep 21, 2021
Subscribe